Gonorrhea Screening Packages in Kathmandu — Bundled STI Panels Multi-STI Packages — One Visit, Complete Coverage

Overview of Gonorrhea Screening Packages

A gonorrhea screening package is a bundled laboratory and consultation service that tests for gonorrhoea together with the other sexually transmitted infections that share its risk factors and transmission routes. Because gonorrhoea rarely travels alone — chlamydia co-infects in a substantial proportion of cases, and HIV, syphilis and hepatitis B and C all spread through the same unprotected sexual contact — screening for gonorrhoea alone leaves most of the picture unexamined.

The clinical logic behind bundled packages is straightforward. Infections acquired in the same encounter are often acquired together, and treating only one leaves the patient still infectious through the others. A single visit that covers several sites and several organisms is more thorough, usually cheaper per test, and gives the clinician the complete picture needed to plan treatment, partner notification and follow-up testing.

Packages are particularly valuable for people with recurrent risk — multiple partners, inconsistent condom use, partners whose status is unknown, or anyone attending pre-marital or pre-pregnancy screening. For low-risk individuals, even a periodic package is a reasonable baseline. What matters is that the package is matched to the actual exposures: someone with receptive anal sex needs a rectal swab, not just a urine sample.

At Thamel Clinic, gonorrhea screening packages are structured around site-matched nucleic acid amplification testing combined with serology for the bacterial and viral infections. Every positive result leads to treatment planning, partner guidance and retesting where indicated, so a package is a complete pathway rather than a test report.

What a Gonorrhea Screening Package Includes

The core of any package is a nucleic acid amplification test (NAAT) for gonorrhoea, usually performed on a urine sample for urethral infection or on site-specific swabs for rectal and pharyngeal infection. NAAT is the recommended diagnostic method because it detects the organism’s genetic material directly and is far more sensitive than older culture or microscopy methods.

A meaningful package adds chlamydia NAAT — the two infections are so frequently co-transmitted that testing for one without the other is incomplete. Serological tests for syphilis (a treponemal test plus a non-treponemal test such as RPR or VDRL) and HIV (a fourth-generation antigen/antibody test) complete the bacterial and viral picture, with hepatitis B surface antigen and hepatitis C antibody added where indicated.

Some packages also include a clinical examination and risk assessment. This matters because the right sample depends on the exposures: receptive anal intercourse requires a rectal swab, oral sex a pharyngeal swab, and vaginal or urethral sex a urine or vaginal sample. A package that collects only urine will miss extragenital infections entirely.

• Gonorrhoea NAAT on the correct anatomical site — urine, urethral, rectal, pharyngeal or vaginal as indicated
• Chlamydia NAAT on the same sites, since the two infections share transmission routes
• Syphilis serology with both treponemal and non-treponemal tests for staging
• HIV fourth-generation antigen/antibody screening
• Hepatitis B surface antigen and hepatitis C antibody where part of the panel
• Confidential result delivery and a treatment plan for any positive finding

Why Screen for More Than Gonorrhea

The epidemiological argument for bundling is that STIs cluster. The behaviours that transmit gonorrhoea — unprotected vaginal, anal or oral sex, multiple partners, concurrent partnerships — transmit chlamydia, syphilis and HIV through exactly the same routes. A person diagnosed with gonorrhoea has a meaningful probability of carrying one or more other infections, and many are asymptomatic.

Extragenital infections illustrate this best. Rectal and pharyngeal gonorrhoea and chlamydia are frequently asymptomatic, yet they persist as reservoirs that reinfect partners and, in the case of HIV, increase susceptibility. Testing only urine misses these entirely. A package that includes site-matched swabs catches what single-site screening cannot.

There is also a practical and economic case. Each additional test added to an existing blood draw or visit costs far less than a separate appointment, separate phlebotomy and separate result cycle. For patients paying privately, the package is almost always the better value — and it removes the temptation to test only for the infection they are worried about.

• STIs share risk factors — the same exposure that causes one causes others
• Asymptomatic infections are common, especially extragenital and early HIV
• Co-infection changes treatment — some combinations need adjusted regimens
• Partner notification is more complete when all infections are known
• Bundled pricing is typically cheaper per organism than separate tests

How the Screening Process Works

The process begins with a confidential consultation. The clinician takes a sexual history — partners, practices, condom use, symptoms and timing of exposures — because this determines which sample sites are needed and whether any test falls outside its window period. Patients should answer honestly; the history is what makes the package accurate rather than generic.

Samples are then collected: urine or swabs for NAAT, a blood sample for serology. Where indicated, the clinician performs a brief examination of the genital area and any visible lesions, since an ulcer or discharge can point to syphilis, herpes or another infection not on the standard panel.

Results are typically available within one to three working days depending on the assays. Every positive is followed by confirmatory testing where required, an explanation of what the result means, and a treatment plan. Gonorrhoea and chlamydia are treated with antibiotics — gonorrhoea currently with injectable ceftriaxone — and partners need testing and treatment too.

• Confidential sexual history and risk assessment before sampling
• Site-matched urine and swab collection based on reported exposures
• Blood draw for HIV, syphilis and hepatitis serology
• Results within 1–3 working days; positive results confirmed and explained
• Treatment prescription, partner notification advice and retesting schedule

Who Should Choose a Package

Packages are the sensible default for anyone with ongoing sexual risk: people with multiple or new partners, inconsistent condom use, partners of unknown status, sex workers, MSM, and patients with a recent diagnosis of any STI. If you have just had unprotected sex with a new partner, a package is the most efficient way to establish your status across the board.

They are also valuable for specific life events. Pre-marital couples, people planning pregnancy, IVF candidates and patients starting immunosuppressive treatment all benefit from complete screening rather than a single test. Routine screening packages — annual or after each new relationship — are standard public health practice for sexually active adults.

Even lower-risk individuals can use a package as a baseline. The cost of missing an asymptomatic chlamydia or early HIV infection far exceeds the cost of the test, and a clean package result provides reassurance that lasts until the next risk event.

• New or multiple partners, or a partner of unknown STI status
• Unprotected vaginal, anal or oral sex
• A recent STI diagnosis — reinfection and co-infection are common
• Pre-marital, pre-pregnancy or fertility workup screening
• Periodic routine screening even without symptoms
• Symptomatic patients — discharge, pain on urination, ulcers or lumps

What Happens After a Positive Result

A positive gonorrhoea or chlamydia result is treated with antibiotics chosen for local resistance patterns — ceftriaxone for gonorrhoea, doxycycline or azithromycin for chlamydia — and both partners must be treated to prevent immediate reinfection. Abstinence or barrier protection is advised until both partners complete treatment.

Syphilis requires staging and longer treatment depending on the stage; HIV requires confirmatory testing and linkage to care; hepatitis results determine vaccination or referral. Each infection on the panel has its own pathway, which is why the clinician explains every positive result individually.

Retesting is part of the package. Gonorrhoea and chlamydia patients should retest around three months after treatment because reinfection is common, and HIV and hepatitis results may need follow-up testing to confirm chronicity. A package is not complete until the follow-up is done.

• Antibiotic treatment for gonorrhoea and chlamydia, with adherence instructions
• Partner testing and treatment to break the reinfection cycle
• Confirmatory testing for HIV, syphilis and hepatitis positives
• Retest at around three months to detect reinfection
• Counselling on prevention — condoms, PrEP for HIV where indicated

Screening Packages & Costs in Kathmandu

Prices are indicative NPR ranges; confirm current rates when booking. Panel composition may vary — ask which organisms and sites are included.

Related Services & Guides